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T	 cells	with	 antimicrobial	 and	 immunoregulatory	 activity,	 recently	 found	 to	 be	 de-
pleted	in	blood	of	patients	with	HIV	and	HCV	mono-	infections.	In	this	study,	we	as-




opsies	 were	 studied	 using	 flowcytometry	 for	 CD3+CD161+Vα7.2+	 MAIT-	cell	 fre-
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1  | INTRODUCTION

















viral	 infections,	 including	HCV	 infection,	 also	 activate	MAIT-	cells	 in	
a	TCR-	independent	fashion	dependent	on	cytokines.8	MAIT-	cells	are	
identified	in	blood	as	CD3+CD161+Vα7.2+	cells,	and	comprise	about	
5%	of	 the	 total	T	 cells	 in	 blood	of	 healthy	 individuals.9,10	 Similar	 to	
NK-	cells,	MAIT-	cells	can	be	activated	by	interleukin	(IL)-	12	and	IL-	1811 
to	produce	high	levels	of	IFN-	gamma	and	the	cytotoxic	enzyme	gran-











infected	 patients.8,15,16	 In	 these	 patients,	MAIT-	cells	were	 depleted	
from	 peripheral	 blood,	 and	 successful	 interferon-	free	 therapy	 was	










associated	with	 enhanced	 translocation	 of	 gut	microbial	 products	 in	








2  | MATERIALS AND METHODS



























N 9 9 11 9 13 9
Gender	(%	male) 100% 100% 100% 100% 100% 100%
Age	(y) 40	(28-	50) 54	(45-	68) 51	(47-	57) 47	(31-	58) 48	(23-	71) 52	(50-	67)
ALT	(U/L) 57	(24-	95) 100	(38-	211) 25	(21-	31) 56	(20-	270) 67	(32-	132)
HCV	RNA	(IU/mL) 4.38	×	106 2.90	×	106 2.15	×	106 1.30	×	106
HCV	genotype	1/2/3/4 8/0/0/1 8/1/1/1 9/1/0/3 7/0/2/0
HIV	load	(geg/mL) All	<20 All	<20 All	<20





patients	 with	 chronic	 HCV	 infection	 (n	=	10)	 and	 cART-	suppressed	






included,	 aged	 between	20	 to	 71	years	 old,	with	 undetectable	viral	
HIV	RNA	 levels,	 compliant	use	of	 cART	and	no	 further	 comorbidity	
like:	autoimmune	disease,	cancer,	co-	infection	with	non-	related	viral	
or	sexual	transmitted	infections.
2.2 | Acquisition of peripheral blood mononuclear 
cells and liver cells
FNAB	 for	 intrahepatic	 cells	 were	 performed	 as	 described	 before.23,24 























antibodies	were	 purchased	 from	 eBioscience	 (San	Diego,	 CA,	 USA),	
Beckman	(Brae,	CA,	USA)	or	Biolegend	(London,	UK).
2.4 | Analysis of intracellular cytokines by 
flowcytometry













eFluor450(HP-	3G10),	 anti-	TCR	 Vα7.2-	PE(3C10),	 CD56-	APC(N901,	
Beckman)	 and	 Live/dead	 Aqua,	 fixed,	 permeabilized	 and	 stained	
with	 anti-	IFN-	γ-	PE-	Cy7(4S.B3)	 and	 anti-	granzyme-	B-	FITC(GB11).	






Flowcytometric	 data	 were	 analysed	 using	 Flow JoTM	 (TreesTar,	
windows 7	 version	 10.0.8).	 Statistical 	 comparison	 was	 performed	
using	 the	Kruskal-	Wallis	 and	Mann-	Whitney	 test	 for	 unpaired	non-	
parametric	analyses.	A	P	value	≤	.05	was	considered	significant.
3  | RESULTS
3.1 | MAIT- cells are severely depleted in blood of 
HCV, HIV and HCV/HIV patients
It	has	been	reported	that	MAIT-	cells	are	depleted	in	blood	of	HIV	and	
HCV	patients.8,11,15,16,19,25-30	We	confirmed	these	findings	by	perform-












3.2 | Effector functions of blood MAIT- cells are 
preserved in HCV, HIV and HCV/HIV patients with low 
levels of liver disease
MAIT-	cells	 can	be	 triggered	by	 stimuli,	 such	 as	 the	TLR7/8	 agonist	
R848,	 E. coli	 and	 the	 cytokines	 IL-	12/IL-	18	 to	 exert	 their	 effector	
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functions.9,11,22	 MAIT-	cells	 of	 healthy	 individuals	 stimulated	 with	
E. coli	 or	 R848	 alone	 exhibited	 low	 frequencies	 of	 cells	 producing	
IFN-	γ	 or	 the	 cytolytic	 enzyme	 granzyme-	B,	 whereas	 IL-	12/IL-	18	
stimulation	 resulted	 in	 18%	 IFN-	γ+	 and	 7.5%	 granzyme-	B+	 MAIT-	
cells	(Figure	2).	Additional	triggering	of	IL-	12/IL-	18	with	either	R848	
or E. coli	 further	 increased	the	frequencies	of	effector-	MAIT-	cells	 in	
healthy	individuals.	Stronger	IFN-	γ	responses	were	detected	after	al-





resulted	 in	robust	 IFN-	γ	production	by	MAIT-	cells	 (see	Figs.	S4	and	
S5).	IFN-	γ	production	by	MAIT-	cells	could	be	further	enhanced	by	the	
addition	of	either	anti-	CD28	or	IL-	12/IL-	18	(see	Figs.	S4	and	S5).
Next,	 we	 studied	 the	 impact	 of	 chronic	 HCV,	 HIV	 and	 chronic	







individuals.	HIV	mono-	infected	patients	 generally	 showed	 increased	
IFN-	γ	 and	 granzyme-	B	 production	 and	 upon	 E. coli	 in	 addition	 to	
IL-	12/IL-	18	 stimulation,	 we	 even	 observed	 a	 65%	 increase	 in	 IFN-	
γ-	producing	MAIT-	cells	 (Figure	2A).	 It	 is	 important	 to	 note	 that	 the	







of	 blood	NK-	cells	 spontaneously	 expressed	 granzyme-	B,	which	was	
increased	 to	 almost	 all	 blood	NK-	cells	 upon	 stimulation	with	 IL-	12/
IL-	18,	E. coli	or	R848	(Fig.	S2	and	data	not	shown).
Overall,	 these	 findings	 show	 that	 despite	 lower	 frequencies	 of	
MAIT-	cells	 in	blood,	 the	 function	of	MAIT-	cells	obtained	 from	HCV	
or	HCV/HIV	patients	without	or	with	minimal	fibrosis	(F0-	F1)	is	main-
tained	 as	 compared	 to	 healthy	 individuals,	 or	 even	 enhanced	 upon	
stimulation	with	E. coli	and	IL-	12/IL-	18	in	HIV	patients.
3.3 | MAIT- cell frequencies are more depleted in 
blood of HCV/HIV co- infected patients with severe 





with	only	mild	fibrosis	 (F0-	F1)	that	were	also	 included	 in	Figures	1	





respectively).	 Importantly,	 the	 frequencies	 of	 CD3+CD161−TCR	
Vα7.2+	cells	were	not	significantly	different	 in	patients	with	F3-	F4	
as	 compared	 to	 F0-	F1,	 and	 loss	 of	 CD161	 could	 not	 explain	 the	
decrease	 in	 CD3+CD161+TCR	Vα7.2+MAIT-	cells	 (data	 not	 shown).	
In	addition,	 frequencies	of	NK-	cells	were	not	modulated	as	a	con-
sequence	 of	 differences	 in	 fibrosis	 scores	 in	 either	 patient	 group	
(Figure	3A).
The	 frequency	 of	 CD38+	 and	 HLA-	DR+	MAIT-	cells	 in	 HCV	 and	
HCV/HIV	co-	infected	patients	was	 significantly	 increased	compared	
to	 those	 of	 healthy	 individuals	 (Figure	1C),	 but	when	 stratifying	 for	
liver	fibrosis	we	observed	no	significant	modulation	of	the	frequency	
of	 CD38+	 or	 HLA-	DR+	MAIT-	cells	 in	 patients	with	 F0-	F1	 vs	 F3-	F4	
(Figure	3B).	Also	for	NK-	cells,	no	significant	differences	were	observed	
when	comparing	the	patients	with	different	fibrosis	scores.
3.4 | Reduced function of MAIT- cells in blood of 
HCV mono- infected patients with severe fibrosis and 
cirrhosis vs no to mild fibrosis
To	 determine	 whether	 fibrosis	 scores	 affected	 the	 functionality	 of	









N 6 4 5 3
Gender	(%	male) 100% 100% 100% 100%
Age	(y) 58	(53-	62) 51	(45-	58) 58	(52-	62) 51	(45-	58)
ALT	(U/L) 57	(24-	95) 103	(60-	147) 49	(20-	79) 61	(45-	81)
HCV	RNA	(IU/mL) 2.72	×	106 5.4	×	106 1.28	×	106 1.24	×	106
HCV	genotype	
1/2/3/4
6/0/0/0 2/0/2/0 4/0/0/1 3/0/0/0
HIV	load	(geq/mL) All	<20 All	<20
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protocol	 for	E. coli	 stimulation	 of	MAIT-	cells,31	we	 confirmed	 these	
findings.	Further,	we	observed	the	same	trend	for	E. coli	stimulation	







observed	 for	blood	MAIT-	cells,	but	not	 for	NK-	cells	 from	 the	 same	
patients	(Fig.	S3).
In	summary,	our	findings	suggest	that	MAIT-	cell	effector	functions	
are	 reduced	 in	HCV	mono-	infected	patients	with	 severe	 liver	 fibro-
sis	and	cirrhosis	as	reflected	by	reduced	frequencies	of	granzyme-	B+ 
MAIT-	cells	upon	stimulation	with	IL-	12/IL-	18.
3.5 | Ex vivo intrahepatic MAIT- cells do not differ in 




tients	without	or	with	only	mild	 fibrosis	 (F0-	F1)	were	 relatively	 low	
(HCV	liver:	median	1.11%;	HCV/HIV	liver:	median	1.08%	of	the	total	



































































































































































Readout:   % 
granzyme B+






















to	 healthy	 individuals.	 Further	 supported	 by	 the	 findings	 that	 in	 all	
patient	 groups	 enhanced	 CD38	 and	 HLA-	DR	 expression	 was	 ob-
served,	 it	 is	clear	that	blood	MAIT-	cells	are	fully	 functional	 in	these	
patients.	Interestingly,	in	HIV	mono-	infected	patients,	but	not	in	HCV	
mono-	infected	or	co-	infected	patients,	we	even	observed	 increased	
frequencies	 of	 IFN-	γ-	 and	 granzyme-	B-	producing	 MAIT-	cells	 with	
certain	stimuli,	which	further	supports	that	their	 functionality	 is	not	
impaired.
Since	 MAIT-	cells	 are	 abundantly	 present	 in	 human	 liver	 perfu-
sates21,22	and	important	in	antimicrobial	 immunity,	we	examined	the	
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our	 earlier	 study	 in	 an	 independent	 cohort.16	Moreover,	MAIT-	cells	
from	HCV/HIV	co-	infected	patients	with	severe	fibrosis	are	not	more	
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counterparts	with	low	fibrosis	scores.	Both	in	F3-	F4	patients	with	HCV	
mono-	infections	 as	well	 as	 in	 patients	with	HCV/HIV	 co-	infections,	
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of	healthy	individuals.21,22	It	is	important	to	examine	in	future	studies	




the	distribution	of	MAIT-	cells	 in	healthy	 individuals	 and	HIV	mono-	
infected	patients	is	needed.	Notwithstanding	the	profound	relevance,	
acquisition	of	these	data	 is	challenging	because	of	difficult	 inclusion	
of	 patients	 and	 healthy	 volunteers,	 and	 partly	 because	 of	 ethical	
constraints.
Another	 suggested	 explanation	 for	 the	 depletion	 of	
CD3+CD161+TCR	Vα7.2+MAIT-	cells	is	downregulation	of	CD161.28,33 
Indeed,	we	observed	an	increase	in	CD3+CD161−TCR	Vα7.2+	cells	in	









Vα7.2+	 cells	 in	 healthy	 individuals,34	 and	 in	 HIV-	infected	 patients,	
MR1	tetramers	did	not	bind	to	CD3+CD161−TCR	Vα7.2+	cells.29
At	 present,	 it	 is	 unknown	 if	 the	 dysfunctional	 blood	MAIT-	cells	
in	 HCV	mono-	infected	 patients	 and	 reduced	MAIT-	cell	 numbers	 in	
blood	of	HCV/HIV	co-	infected	 individuals	are	the	cause	or	the	con-
sequence	of	the	more	severe	liver	fibrosis.	Low	MAIT-	cell	frequencies	















patients	 is	more	pronounced	 in	 individuals	with	 severe	 liver	 fibrosis	
or	cirrhosis	as	compared	to	those	without	or	with	only	mild	fibrosis.	
Moreover,	evaluation	of	aspirate	biopsies	of	the	liver	provided	no	ev-
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